The Valley Desk

NCT01300988 · Interventional trial

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

Overall registry status Completed

Phase 1

Conditions HIV Infection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov